Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liping Su

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
International Journal of Clinical and Experimental Pathology|January 23, 2020
Fourth malignancy after treatment of Hodgkin's lymphoma: a case reportWei Gui, Liping Su, Jingrong Wang, et al.
Experimental and Therapeutic Medicine|May 8, 2018
Leptin attenuates the growth of rabbit mesenchymal stem cells via the extracellular signal-regulated kinase signaling pathwayLiping Su, Qiao Qiao, Ruifeng Li, et al.
Open Life Sciences|June 6, 2024
Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphomaJin Zhao, Xiaojing Guo, Meijing Zheng, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 28, 2010
Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistanceLiping Su, Ying Wang, Mingzhen Xiao, et al.
Frontiers in Oncology|June 20, 2022
Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin LymphomaJing Yang, Limin Chai, Junting Jia, et al.
European Journal of Public Health|November 21, 2024
Causal association of physical activity with lymphoma risk: a Mendelian randomization analysisJin Zhao, Xiaolian Wen, Meijing Zheng, et al.
Annals of Hematology|July 13, 2023
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemiaJin Zhao, Li Ma, Meijing Zheng, et al.
Leukemia & Lymphoma|March 3, 2026
Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trialChong Wei, Liping Su, Lihong Liu, et al.
Experimental Oncology|April 7, 2005
A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cellsSiguo Hao, Liping Su, Xulin Guo, et al.
Heliyon|May 3, 2024
From spear to trident: Upgrading arsenal of CAR-T cells in the treatment of multiple myelomaJin Zhao, Meijing Zheng, Li Ma, et al.
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
International Journal of Clinical and Experimental Pathology|January 23, 2020
Fourth malignancy after treatment of Hodgkin's lymphoma: a case reportWei Gui, Liping Su, Jingrong Wang, et al.
Experimental and Therapeutic Medicine|May 8, 2018
Leptin attenuates the growth of rabbit mesenchymal stem cells via the extracellular signal-regulated kinase signaling pathwayLiping Su, Qiao Qiao, Ruifeng Li, et al.
Open Life Sciences|June 6, 2024
Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphomaJin Zhao, Xiaojing Guo, Meijing Zheng, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 28, 2010
Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistanceLiping Su, Ying Wang, Mingzhen Xiao, et al.
Frontiers in Oncology|June 20, 2022
Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin LymphomaJing Yang, Limin Chai, Junting Jia, et al.
European Journal of Public Health|November 21, 2024
Causal association of physical activity with lymphoma risk: a Mendelian randomization analysisJin Zhao, Xiaolian Wen, Meijing Zheng, et al.
Annals of Hematology|July 13, 2023
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemiaJin Zhao, Li Ma, Meijing Zheng, et al.
Leukemia & Lymphoma|March 3, 2026
Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trialChong Wei, Liping Su, Lihong Liu, et al.
Experimental Oncology|April 7, 2005
A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cellsSiguo Hao, Liping Su, Xulin Guo, et al.
Heliyon|May 3, 2024
From spear to trident: Upgrading arsenal of CAR-T cells in the treatment of multiple myelomaJin Zhao, Meijing Zheng, Li Ma, et al.
Pageof 26